Abstract:4933 The chemotherapy of advanced hormone refractory prostate cancer is severely compromised by drug resistance and dose limiting toxicity. Here we tested whether selenium could enhance the apoptosis potency of selected chemotherapeutic drugs in DU145 and PC3 human androgen-independent prostate cancer cells. Exponentially growing cells were exposed to low doses of selenium and/or the topoisomerase I poison 7-ethyl-10-hydroxycamptothecin (SN38), the topoisomerase II inhibitor etoposide or the microtubule drug paclitaxel/taxol. Apoptosis was measured by ELISA for histone-associated DNA fragments, by flow cytometric analysis of sub-G1 fraction, and by immunobloting the caspase cleaved poly(ADP-ribose)polymerase. Our results show that the methylselenol precursor methylseleninic acid (MSeA) increased the apoptosis potency of SN38, etoposide or paclitaxel by several folds higher than the expected sum of the apoptosis induced by MSeA and each drug alone in both cell lines. Mechanistically, the combination treatment did not further enhance the phosphorylation of c-Jun N-terminal kinase (JNK)1/2 that was induced by each drug in DU145 cells. The JNK inhibitor SP600125 substantially decreased the activation of caspases and apoptosis induced by MSeA combination with the drugs. The caspase-8 inhibitor zIETDfmk completely abolished apoptosis and caspase-9 and caspase-3 cleavage, whereas the caspase-9 inhibitor zLEHDfmk significantly decreased caspase-3 cleavage and apoptosis but had no effect on caspase-8 cleavage. None of these caspase inhibitors abolished JNK1/2 phosphorylation. In contrast to MSeA, selenite did not show any enhancing effect on the apoptosis induced by these drugs. In conclusion, MSeA enhanced apoptosis induced by cancer therapeutic drugs in DU145 cells primarily through interactions between MSeA and JNK-dependent targets to amplify what appeared to be a caspase-8-initiated activation cascade. The results suggest, to our knowledge, for the first time a novel use of methyl selenium for improving the chemotherapy of prostate cancer. Grant supports: CA92231 and CA95642 from NCI and DAMD17-02-1-0007 from DOD.

Natural Borneol, a Monoterpenoid Compound, Potentiates Selenocystine-Induced Apoptosis in Human Hepatocellular Carcinoma Cells by Enhancement of Cellular Uptake and Activation of ROS-mediated DNA Damage.

Sodium Selenite Induces Apoptosis Via ROS‐mediated NF‐κB Signaling and Activation of the Bax–caspase‐9–caspase‐3 Axis in 4T1 Cells

Natural Borneol Enhances Bisdemethoxycurcumin-Induced Cell Cycle Arrest in the G2/M Phase Through Up-Regulation of Intracellular ROS in HepG2 Cells.

Synergistic Apoptosis-Inducing Effects on A375 Human Melanoma Cells of Natural Borneol and Curcumin

Selenocystine induces oxidative-mediated DNA damage via impairing homologous recombination repair of DNA double-strand breaks in human hepatoma cells

Enhancing effect of natural borneol on the cellular uptake of demethoxycurcumin and their combined induction of G2/M arrest in HepG2 cells via ROS generation

Enhanced Anticancer Efficiency of Doxorubicin Against Human Glioma by Natural Borneol Through Triggering ROS-mediated Signal.

Natural Borneol Enhances Paclitaxel-Induced Apoptosis of ESCC Cells by Inactivation of the PI3K/AKT.

Selenocystine Induces Reactive Oxygen Species-Mediated Apoptosis in Human Cancer Cells

Selenocystine Potentiates Cancer Cell Apoptosis Induced by 5-Fluorouracil by Triggering Reactive Oxygen Species-Mediated DNA Damage and Inactivation of the ERK Pathway

TRPM8-regulated Calcium Mobilization Plays a Critical Role in Synergistic Chemosensitization of Borneol on Doxorubicin

Mitochondria-mediated apoptosis in human breast carcinoma MCF-7 cells induced by a novel selenadiazole derivative.

Strategy to Enhance the Therapeutic Effect of Doxorubicin in Human Hepatocellular Carcinoma by Selenocystine, A Synergistic Agent That Regulates the Ros-Mediated Signaling

Synthesis of Selenazolopyridine Derivatives with Capability to Induce Apoptosis in Human Breast Carcinoma MCF-7 Cells Through Scavenge of Intracellular ROS.

Betacyanins Functionalized Selenium Nanoparticles Inhibit HepG2 Cells Growth Via Mitochondria-Mediated Pathway

Selenocystine Induces Caspase-Independent Apoptosis in MCF-7 Human Breast Carcinoma Cells with Involvement of P53 Phosphorylation and Reactive Oxygen Species Generation.

Methylseleninic acid potentiates apoptosis induced by chemotherapeutic drugs in prostate cancer cells through enhancing caspase activation

Synergism Between Thioredoxin Reductase Inhibitor Ethaselen and Sodium Selenite in Inhibiting Proliferation and Inducing Death of Human Non-Small Cell Lung Cancer Cells.

Methylseleninic Acid Potentiates Apoptosis Induced By Chemotherapeutic Drugs In Androgen-Independent Prostate Cancer Cells

Anticancer Activity of Biogenically Synthesized Selenium Nanoparticles Using Catharanthus Roseus

New Organoselenium (NSAIDs-Selenourea and Isoselenocyanate) Derivatives as Potential Antiproliferative Agents: Synthesis, Biological Evaluation and in Silico Calculations